Under to the scheme, which Biden is expected to announce in the UK on Thursday, the US would pay for the vaccines at cost price. The first 200m doses would be distributed this year, and the remaining 300m in the first half of next year.
Emmanuel Macron also supports US-backed proposal described as a game-changer by WHO.
Covid vaccines: what is patent waiving and will it solve the global shortage?
About 80 people at a clinic in Mexico received a fake COVID-19 vaccine going for about $1,000 a dose, the Wall Street Journal reported earlier Wednesday. The individuals did not appear to have been physically harmed, according to the outlet.
"The rate of infection in Israel is very low thanks to the successful vaccine campaign in Israel, and therefore it is possible to ease (restrictions)," Edelstein said.
He said however that masks will still be required indoors.
Pfizer CEO has also said it is ‘likely’ people will need a third coronavirus vaccine dose within a year
The request asks the U.S. Food and Drug Administration to amend its Emergency Use Authorization, which was originally granted in December for people ages 16 and older.
Pfizer and BioNTech said on Thursday their vaccine is around 91% effective at preventing COVID-19, citing updated trial data that included participants inoculated for up to six months.
Pfizer and BioNTech said on Wednesday their COVID-19 vaccine was safe and effective and produced robust antibody responses in 12- to 15-year olds, paving the way for them to seek U.S. emergency use authorization in weeks.
